Cost-effectiveness of influenza vaccination in high-risk children in Argentina

2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals

“…Economic evaluations of vaccinating children have demonstrated a wide range of cost estimates, but have generally found this strategy to be either costsaving or cost-beneficial. [292][293][294][295] A comparison of the economics of vaccinating children with TIV or LAIV found similar cost savings between the two vaccines, with an increased cost for both vaccines for older versus younger children. [296] Analyses of vaccination programs targeting pregnant women show that it is cost-effective.…”

Economic evidence of influenza vaccination in children

“…Eleven articles were thus retained [16,23,26-] [ 28,[34][35][36][37][38][39]. The database search was complemented by manually screening for in-press articles in journals that publish health economic, paediatric, or immunisation articles (three articles were identified) and by screening the reference lists of the selected articles (one article identified) [25,29,30,40].…”

Rekurren influenza infections with an asthmatic children.

“…Bunun yanında, özel-likle hastane yatışları ve influenza ilişkili komplikasyonlardan belirgin olarak korumaktadır (7,8) . kardiyak, solunum yolu hastalıkları ve uzun dönem immünsüpresif ya da aspirin tedavisi gören tüm çocuklarda influenza enfeksiyonu ile ilişkili hastane başvurusu ve komplikasyon gelişimi sağlıklı çocuk-lara göre 2-4 kat fazla olduğundan influenza aşısı önerilmektedir (6) .…”